Prospective Evaluation of Breast-Conserving Surgery Alone in Low-Risk Ductal Carcinoma in Situ (DCIS) (NCT04797299)
Prospective Evaluation of Breast-Conserving Surgery Alone in Low-Risk Ductal Carcinoma in Situ Defined by a Molecular Expression Assay Combined With Clinico-Pathological Features
🩺 Plain-English Summary (8th-Grade Level)
To evaluate whether the combination of clinicopathological factors and the use of the Oncotype DX DCIS score can avoid radiation in women with low risk DCIS who have had breast conserving surgery (BCS)
Who can join: Review the eligibility criteria below.
Location: Arthur J.E. Child Comprehensive Cancer Centre — Calgary, Alberta
Age range: 46 Years
📋 "Do I Qualify?" — 1-Minute Self Screener
Instant ChecklistFull eligibility criteria are available on the official NIH protocol. View the criteria ↗
📍 All Participating Trial Locations (25 Sites)
- Arthur J.E. Child Comprehensive Cancer Centre — Calgary, Alberta
- Cross Cancer Institute — Edmonton, Alberta
- BC Cancer - Abbotsford Centre — Abbotsford British Columbia, British Columbia
- BC Cancer - Centre for the North (Prince George) — Prince George, British Columbia
- BC Cancer - Fraser Valley Centre — Surrey, British Columbia
- BC Cancer - Vancouver Centre — Vancouver, British Columbia
- BC Cancer - Victoria — Victoria, British Columbia
- CancerCare Manitoba — Winnipeg, Manitoba
- QE II HSC - Nova Scotia Cancer Centre — Halifax, Nova Scotia
- Cape Breton Cancer Centre — Sydney, Nova Scotia
- Royal Victoria Regional Health Centre — Barrie, Ontario
- Juravinski Cancer Centre — Hamilton, Ontario
- London Regional Cancer Program — London, Ontario
- Regional Cancer Care, Thunder Bay Regional Health Sciences Centre — Thunder Bay, Ontario
- Sunnybrook Health Science Centre -Odette Cancer Centre — Toronto, Ontario
- University Health Network - Princess Margaret Cancer Centre — Toronto, Ontario
- Windsor Regional Cancer Centre — Windsor, Ontario
- Hôpital Charles Le Moyne (CISSS de la Montérégie-Centre) — Greenfield Park, Quebec
- CHUM - Centre Hospitalier de L'Université de Montréal — Montreal, Quebec
- Jewish General Hospital — Montreal, Quebec
- McGill University Health Centre — Montreal, Quebec
- Centre intégré de cancérologie du CHU de Québec - Université Laval — Québec, Quebec
- Centre Intégré Universitaire de Santé et de Services Sociaux de la Mauricie- Centre-du-Québec (CIUSSS MCQ) - Trois-Rivières — Trois-Rivières, Quebec
- Allan Blair Cancer Centre — Regina, Saskatchewan
- Saskatoon Cancer Centre — Saskatoon, Saskatchewan
📞 Contact the Study Coordinator
Phone: (905) 527-2299
Email: spelleb@mcmaster.ca
Coordinator details come directly from the registered NIH protocol. Confirm the study is still recruiting before traveling.
💰 Cost, Insurance & Patient Rights
- 100% Free Items: The investigational treatment and protocol-required procedures are supplied at zero cost by the sponsor.
- Routine Patient Care: Under federal law (ACA § 2709) and many state statutes, routine care costs are covered during participation.
- Voluntary Participation: You may withdraw at any time without affecting your standard medical care.
More studies in DCIS
- Comparing an Operation to Monitoring, With or Without Endocrine Therapy (COMET) Trial For Low Risk DCIS — Anchorage, Alaska
- The PREDICT Registry: — Scottsdale, Arizona
- Delayed Sentinel Lymph Node Biopsy in Ductal Cancer in Situ — Houston, Texas
Explore by condition: All DCIS clinical trials
💡 How to Participate
- Check the checklist above to see if you may qualify.
- Contact the study coordinator using the phone/email above.
- Ask about the visit schedule, what is covered at no cost, and any travel support.
- Confirm with your own doctor before making a decision.